Intravenous Vitamin C in the Treatment of Shingles: Results of a Multicenter Prospective Cohort Study
This multicenter prospective cohort study evaluated the efficacy and safety of intravenous vitamin C (IVC) in treating shingles (herpes zoster). Sixty-seven patients received IVC (7.5 g per infusion) over approximately two weeks. Results indicated significant reductions in pain and dermatological symptoms, with a lower incidence of post-herpetic neuralgia (PHN) compared